MARKET

ATHX

ATHX

Athersys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.260
+0.020
+1.61%
After Hours: 1.300 +0.04 +3.17% 18:26 02/19 EST
OPEN
1.260
PREV CLOSE
1.240
HIGH
1.290
LOW
1.230
VOLUME
683.26K
TURNOVER
--
52 WEEK HIGH
2.030
52 WEEK LOW
1.160
MARKET CAP
197.40M
P/E (TTM)
-4.0475
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ATHX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ATHX News

  • Athersys And The Law Of Large Numbers
  • Seeking Alpha - Article.1d ago
  • Athersys to Host Year-End 2019 Financial Results Call
  • Business Wire.02/10 13:00
  • Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  • Business Wire.02/03 11:00
  • How Much Did Athersys, Inc.'s (NASDAQ:ATHX) CEO Pocket Last Year?
  • Simply Wall St..01/24 10:36

More

Industry

Biotechnology & Medical Research
+1.22%
Pharmaceuticals & Medical Research
+0.32%

Hot Stocks

Name
Price
%Change

About ATHX

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
More

Webull offers Athersys, Inc. (ATHX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.